Advertisement

July 3, 2024

AI Diagnostics, Private Equity in Your Practice

In This Episode

John Bertrand (CEO, Digital Diagnostics) speaks with us about LumineticsCore, an AI diagnostic system that autonomously diagnoses patients for diabetic retinopathy, including macular edema, to detect disease before it leads to blindness. Also, regular contributor Dr. MedLaw discusses the role of private equity in your practice.

Enjoy Listening!

Changes Are Coming Soon!

Stay tuned for an exciting new format, dropping July 10!

Advertisement
CONTENT CONTINUES BELOW
Alex McDonald, MD

John Bertrand

Digital Diagnostics
Co-Founder and Chief Executive Officer

Scott Nass, MD

Dr. MedLaw

Advertisement
Advertisement

Author